ImmunEscpMap Logo. In the middle is a cluster of cancer cells. The immune cells are blocked and the immune infiltration is suppressed.

Home

Download

Statistics

Landscape

Help

Contact

Instructions for Navigating the Site

1. ImmunEscpMap information
2. Webpage navigation
    a. Search by Gene symbol or Entrez gene ID
    b. Browse by cancer type or immune escape mechanism
3. Understanding gene annotation of ImmunEscpMap
    a. Gene summary
    b. Literature curation
    c. Tumor vs Normal
        i. Gene expression
        ii. Methylation
        iii. Copy number variation
    d. Mutated vs Wildtype: DEGs and enrichment analysis
    e. Non-responders vs Responders after immunotherapy
    f. Tumor infiltrating lymphocytes
    g. Gene expression and immune subtypes/status
    h. Gene-related drugs and diseases
    i. Survival analysis
4. Download data and contact us

bullet point   1. ImmunEscpMap information
The ImmunEscpMap database provides functional analyses of 517 genes related to 8 cancer immune escape mechanisms. The figures illustrates the key idea of each mechanism. By clicking on one of the cancer types or immune escape mechanisms, the users can check the list of genes with evidences in literatures. (A) Chemokine: The chemokine ((C-X-C motif) participates in the generation and recruitment of immune cells that contribute to a pro-tumorigenic microenvironment; (B) Endothelial Cell Anergy: During angiogensis, the lack of endothelial adhesion molecules suppress the immune infiltration. In addition, the endothelial cells express immunosuppressive molecules that induce the apoptosis of immune cells; (C) Inducing Apoptosis of Cytotoxic T Cells (CTLs): The cancer cell upregulates FasL, which can bind to Fas expressed by activated T cells, leading to T cell apoptosis; (D) Inhibiting Recruitment of Dendritic Cells: Tumor cell derived PGE2 can inhibit the function of natural killer cells and the recruitment of dendritic cells; (E) Inhibiting Target Recognition: The T cell responses can be inhibited by the involvement of inhibitory ligand, the lack of MHC class I molecules and the loss of neoantigens; (F) Matrix Barrier: The extracellular matrix and surrounding cancer associated fibroblasts can create a physical barrier that suppresses immune cell infiltration; (G) Metabolic Barrier: The dysregulated vasculature reduces oxygen and nutrient levels in the tumor core and prevents metabolites that suppress T cells from being transported out of the tumor; (H) T Cell Dysfunction and Exhaustion: AMPK overexpression inhibits mTOR activity, which modulates downstream transcription factors such as TOX and NR4A1, leading to altered PD-1 expression and contributing to T cell exhaustion and dysfunction.

bullet point 2. Webpage navigation
bullet point a. Search by Gene symbol or Entrez gene ID.
 - Input query: Gene symbol or Entrez gene ID. For example, by searching "Gene symbol: IFNG" or "Entrez gene ID: 3458", the webpage will jump to the gene information for your query.
The users can search a gene symbol or Entrez gene ID. For example, by searching Gene symbol: IFNG or Entrez gene ID: 3458, the webpage will jump to the gene information for your query
bullet point b. Browse by cancer type or immune escape mechanism
 By clicking on one of the cancer types or immune escape mechanisms, the users can check the list of genes with evidences in literatures. By clicking on one of the cancer types or immune escape mechanisms, the users can check the list of genes with evidences in literatures.
bullet point 3. Understanding gene annotation of ImmunEscpMap
bullet point a. Gene summary
 - This image shows the summary information of the queried gene, including the gene symbol, ID, name, synonyms, type, UniProtAcc link and the ontology information (Biological Process only).
This image shows the summary information of the queried gene, including the gene symbol, ID, name, synonyms, type, UniProtAcc link and the ontology information.
bullet point b. Literature curation
 - This image shows the literature records supporting the association of this gene and the cancer immune escape, including the mechanism icon, PMID, cancer type, immune escape mechanism and the evidence sentence. The literature mining was done by extracting abstracts from PubMed database using Esearch and Efetch, and manually filtered genes related to tumor immune evasion. The input keywords were "cancer" and concepts related to 8 mechanisms such as "endothelial cell anergy", "endothelial cell dysfunction", "endothelial immune escape", "matrix barrier", "extracellular matrix", "cancer-associated fibroblasts", "chemokine immune escape", "chemokine immune evasion", "inhibiting MHCI expression", "inhibiting MHCII expression", "inhibiting neoantigen expression", "neoantigen burden", "dendritic cell recruitment", "T cell dysfunction", "T cell exhaustion", "metabolic barrier", "metabolic immune evasion", and "induce CTLs apoptosis".
This image shows the literature records supporting the association of this gene and the cancer immune escape, including the mechanism icon, PMID, cancer type, immune escape mechanism and the evidence sentence.
bullet point c. Tumor vs Normal
 For each cancer type in TCGA, if both the number of tumor and normal samples are no less than 5, we compare the gene expression and methylation level between groups, as well as the correlation between expression and methylation. In addition, we summarize the copy number alteration in tumor samples across cancer types, and the correlation between expression and copy number.
bullet point i. Gene expression
This image shows the difference in gene expression level across cancer types in TCGA. The threshold for adjusted p-value is shown as : ***, padj < 0.001; **: 0.001 < padj < 0.01; 0.01 < padj < 0.05; NS: padj > 0.05.
The difference in gene expression level across cancer types in TCGA. Here is an illustration of six cancer types, BLCA, BRCA, COAD, CHOL, ESCA, and GBM. bullet point ii. Methylation
The boxplot shows the mean beta value in normal and tumor group, and the dotplot shows the correlation between methylation level and expression level. Methylation in promoter and genebody region are analyzed separately.
The difference in methylation level of KDM1A promoter region across cancer types in TCGA. Here is an illustration of six cancer types, BLCA, BRCA, CHOL, COAD, ESCA and GBM. bullet point iii. Copy number variation
This image shows the copy number variation across cancer types in TCGA. The violin plot shows the correlation between copy number and expression level. The gene level copy number is annotated as: 0: homozygous deletion; 1: deletion leading to LOH; 2: wild type, including copy-neutral LOH; 3/4: minor gain; 5-8: moderate gain; >=9: high-level amplification.
This image shows the copy number variation across cancer types in TCGA. The gene level copy number is annotated as: 0: homozygous deletion; 1: deletion leading to LOH; 2: wild type, including copy-neutral LOH; 3/4: minor gain; 5-8: moderate gain; >=9: high-level amplification.
The violin plot shows the correlation between copy number and expression level. bullet point d. Mutated vs Wildtype: DEGs and enrichment analysis
 For each cancer type in TCGA, if there are more than 5 samples with non-synonymous mutations, we calaulated the differentially expressed genes and KEGG, GOBP, Hallmark enriched pathways between mutated and wildtype groups.
This image shows the differentially expressed genes and KEGG, GOBP, Hallmark enriched pathways between mutated and wildtype groups. In this example, there are downregulated GOBP, KEGG, and Hallmark pathways in KDM1A mutated group.
This image shows the differentially expressed genes and KEGG, GOBP, Hallmark enriched pathways between mutated and wildtype groups. In this example, there are downregulated GOBP, KEGG, and Hallmark pathways in KDM1A mutated group. bullet point e. Non-responders vs Responders after immunotherapy
 We collect 16 datasets (10 for expression and 6 for mutation) consisting of at least 2 responders and non-responders and compare the gene expression and mutation difference between groups. The image shows the difference in gene expression level and mutation rate between non-responders and responders after immunotherapy. The significant results (padj < 0.05), including the detailed information of datasets are presented in the table.
The left image shows the difference in gene expression level between responders and non-responders after immunotherapy. Each dot represents a dataset. The x axis represents log2FC and the y axis represents the adjusted p value. The right image shows the difference in mutation rate between responders and non-responders after immunotherapy. Each dot represents a dataset. The x axis represents mutation rate difference and the y axis represents the adjusted p value. bullet point f. Tumor infiltrating lymphocytes
 This heatmap shows the correlation between the gene expression, copy number, methylation, and immune cell abundance.
The image shows the correlation between the gene expression, methylation, cnv and immune cell abundance. Each unit represents the spearman correlation of gene expression/copy number/methylation and an immune cell subtype within one TCGA cancer type. bullet point g. Gene expression and immune subtypes/status
 The violin plots compare the gene expression level in six immune subtypes, escaped(-/+) and different microsatellite instability status respectively. The dotplot shows the correlation between expression level and dN/dS, the ratio of nonsynonymous to synonymous mutations in the immunopeptidome.
The image shows the correlation between the gene expression, methylation, cnv and immune cell abundance. Each unit represents the spearman correlation of gene expression/copy number/methylation and an immune cell subtype within one TCGA cancer type. bullet point h. Gene-related drugs and diseases
 The left network graph shows drugs targetting the gene, derived from the Drug-Gene Interaction Database (DGIdb, https://dgidb.org) 5.0. The right network graph shows the disease-gene associations from curated databases, genome-wide association studies (GWAS) and literature mining, which is obtained from Diseases 2.0 (https://diseases.jensenlab.org/Search).
The image shows the correlation between the gene expression, methylation, cnv and immune cell abundance. Each unit represents the spearman correlation of gene expression/copy number/methylation and an immune cell subtype within one TCGA cancer type. bullet point i. Survival analysis
 This image shows the survival analysis using TCGA data. Kaplan-Meir curves reflects the association of gene expression with overall survival across different cancers. The significance (p value) is assessed by log-rank test.
This image shows the survival analysis using TCGA data. Kaplan-Meir curves reflects the association of gene expression with overall survival across different cancers. The significance (p value) is assessed by log-rank test. bullet point 4. Download data and contact us
Please go to download page and contact page.